Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Study of CHS-114 in Participants With Advanced Solid Tumors
Complete Title: A PHASE 1/2 STUDY OF SRF114 IN PATIENTS WITH ADVANCED SOLID TUMORS
Trial Phase: I
Investigator: Cristina Rodriguez
This is a Phase 1, open-label, first-in-human, dose-escalation and expansion study of SRF114, a monoclonal antibody that targets CCR8, as a monotherapy in patients with solid tumors.
Keywords:
- Carcinoma, Squamous Cell; Advanced Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.